JPRN-UMIN000042905
Recruiting
Phase 3
Postoperative radiotherapy (PORT) for pathological N2 non-small cell lung cancer with adjuvant chemotherapy: a randomized phase III trial - Postoperative radiotherapy (PORT) for pathological N2 non-small cell lung cancer with adjuvant chemotherapy: a randomized phase III trial
Japan Clinical Oncology Group (JCOG)0 sites330 target enrollmentJanuary 5, 2021
Overview
- Phase
- Phase 3
- Intervention
- Not specified
- Conditions
- pathological N2 non-small cell lung cancer
- Sponsor
- Japan Clinical Oncology Group (JCOG)
- Enrollment
- 330
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •(1\)History of synchronous or metachronous (within 3 years) malignancies (2\)Active infection requiring systemic therapy (3\)Fever with a body temperature higher than 38\.0 degrees Celsius at the time of registration (4\)Pregnant, possibly pregnant, within 28 days of delivery, breastfeeding females, or males expecting to father a child (5\)Psychiatric illnesses or symptoms affecting the daily lives (6\)Systemic treatment with steroids or immunosuppressive agents (7\)Unstable angina(diagnosis or worsening of chest pain within 3 weeks) or history of myocardial infarction within 6 months prior to the registration
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, Not Recruiting
Phase 1
Post-operative external radiotherapy combined with concomitant and adjuvant hormonal treatment versus post-operative external radiotherapy alone in pathological stage pT3a-b R0-1 N0M0 / pT2R1 N0M0, Gleason score 5-10 prostatic carcinoma. A Phase III studyEUCTR2006-002772-17-FREuropean Organisation for Research and Treatment of Cancer86
Completed
N/A
Post-operative RadioTherapy for patients with metastases of the long bonesmetastatic bone diseaseskeletal metastasis10028389NL-OMON45060eids Universitair Medisch Centrum6
Completed
Phase 4
Effectiveness of postoperative radiotherapy in patients with oral or oropharyngeal squamous cell carcinoma and histologically confirmed single ipsilateral lymphnode metastasis (pN1)head-neck cancer metastasisoral cancer1002747610019190NL-OMON30589Academisch Medisch Centrum12
Not Yet Recruiting
Phase 2
Adjuvant postoperative high-dose radiotherapy for atypical and malignant meningioma: a Phase-II and observation study (EORTC 22042-26042)NL-OMON32223EORTC30
Completed
N/A
Post-Operative Radiotherapy for Selected High Risk Rectal AdenocarcinomaColorectal cancerCancerColorectalISRCTN91411631orthern and Yorkshire Clinical Trials and Research Unit (UK)